financetom
Business
financetom
/
Business
/
Crisil downgrades non-convertible debentures of IL&FS' Jharkhand road project
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Crisil downgrades non-convertible debentures of IL&FS' Jharkhand road project
Jan 21, 2019 12:53 PM

In a fresh setback for debt-ridden IL&FS, rating agency Crisil has downgraded the non-convertible debentures of a road project in Jharkhand.

Crisil has warned that this and other projects are likely to stop interest rate payments contrary to the company's previous stance.

Last week, state-owned NHIDCL has terminated the contract awarded to troubled IL&FS group for building the strategic Zojila tunnel to provide all-weather connectivity between Srinagar, Kargil and Leh.

IL&FS Transportation in a filing said the contract was terminated on January 15.

IL&FS group has defaulted on debt repayments due to financial mismanagement. The total debt of the group was pegged at Rs 94,215.6 crore as of October 8. The government in October superseded the board of IL&FS and appointed new members to rescue the group.

First Published:Jan 21, 2019 9:53 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Bristol Myers' drug fails main goal in late-stage trial for cancer-related anemia
Bristol Myers' drug fails main goal in late-stage trial for cancer-related anemia
Jul 18, 2025
July 18 (Reuters) - Bristol Myers Squibb ( BMY ) said on Friday its blockbuster drug Reblozyl in combination with another therapy failed to meet the main goal of a late-stage trial to treat anemia due to a rare bone marrow cancer. The study did not achieve statistically significant results in helping patients become free from red blood cell transfusions...
Charles Schwab Q2 Adjusted Earnings, Revenue Rise
Charles Schwab Q2 Adjusted Earnings, Revenue Rise
Jul 18, 2025
07:43 AM EDT, 07/18/2025 (MT Newswires) -- Charles Schwab ( SCHW ) reported Q2 adjusted earnings Friday of $1.14 per diluted share, up from $0.73 a year earlier. Analysts polled by FactSet expected $1.10. Net revenue for the quarter ended June 30 was $5.85 billion, compared with $4.69 billion a year earlier. Analysts surveyed by FactSet expected $5.73 billion. ...
Top Premarket Gainers
Top Premarket Gainers
Jul 18, 2025
07:42 AM EDT, 07/18/2025 (MT Newswires) -- Blaize ( BZAI ) stock was up 99% pre-bell Friday after the company said late Thursday it won a contract with a minimum value of $120 million for its hybrid artificial intelligence platform for deployment in Asia. K-Tech Solutions ( KMRK ) shares were 33% higher following a 10% drop in the previous...
Copyright 2023-2026 - www.financetom.com All Rights Reserved